| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |